Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.
New study raises concerns over serious side effects of weight loss injections
A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, Wegovy, and Mounjaro. The research involved over two million patients and found that those using these medications have double the risk of developing pancreatitis – a potentially life-threatening inflammation of the pancreas.
Weight Loss Injections May Lower The Risk Of 42 Health Conditions, Including Dementia – Study
Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, potentially paving the way for broader treatments.
Sweeping review suggests weight-loss drugs’ effect on 175 conditions
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected but contain surprises, too.
Study finds popular weight loss drugs may help with other health conditions
Obesity expert Dr. Naomi Parrella of Rush University joins Marie Saavedra to talk about the new study and the impact for patients.
Weight-Loss Drugs Show Major Health Benefits but Carry Risks
A major study involving two million people has unveiled surprising effects of weight-loss drugs like Ozempic and Wegovy. While originally designed to treat type 2 diabetes, these medications have been linked to improved heart health fewer infections,
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer and dementia, a sweeping new study shows.
Researchers reveal benefits, risks linked to popular weight-loss drugs
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart disease, and obesity. Commonly marketed under brand names like Ozempic and Wegovy,
I work 3 jobs to pay for my semaglutide weight loss shots — now I’m locked in for life
Getting skinny on weight loss meds takes a fat wad of cash.  And Staci Rice is working double-time for the petite payoffs.  ...
Gemma Collins reveals she’s dropped two dress sizes after using fat loss injections to lose weight
GEMMA Collins has revealed that she’s dropped two dress sizes after turning to fat loss injections. The TV favourite, 43, who ...
Dame Jenni Murray to use weight-loss jabs forever after mum's cruel words on deathbed
Former BBC Radio 4 presenter Dame Jenni Murray has bravely opened up on the lasting impact her mother's obsession with weight ...
'I'm a GP and this is how to tell if you're being sold fake weight loss injections'
While it's illegal to sell certain substances without a prescription, it's possible that you could be sold fake weight loss ...
The FDA is about to make weight-loss drugs a lot harder to get
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Wegovy at Higher Dose Achieves Greater Weight Loss in Trial
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...
Black-market weight drugs put hundreds in hospital with diarrhoea and vomiting
Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...